Tashkin, D. P., Roth, M. D., Clements, P. J., Furst, D. E., Khanna, D., Kleerup, E. C., . . . Elashoff, R. M. (2016). Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial. Lancet Respir Med.
Čikaški stil citiranjaTashkin, Donald P., et al. "Mycophenolate Mofetil Versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a Double-blind, Parallel Group, Randomised Controlled Trial." Lancet Respir Med 2016.
MLA način citiranjaTashkin, Donald P., et al. "Mycophenolate Mofetil Versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a Double-blind, Parallel Group, Randomised Controlled Trial." Lancet Respir Med 2016.